MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus

Circulating MicroRNAs and Monocyte–Platelet Aggregate Formation in Acute Coronary Syndrome

(2021) Stefan Stojkovic et al.   THROMBOSIS AND HAEMOSTASIS

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

(2020) William A. E. Parker et al.   Cardiovascular Diabetology

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel

(2020) Dominick J. Angiolillo et al.   JACC-Cardiovascular Interventions

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2020) Paul Guedeney et al.   Journal of Clinical Medicine

Plasma exosomal miRNAs involved in endothelial injury in microscopic polyangiitis patients

(2020) Yang Wang et al.   FASEB JOURNAL

miR-125a-5p Regulates Megakaryocyte Proplatelet Formation Via the Actin Bundling Protein L-Plastin

(2020) Seema Bhatlekar et al.   BLOOD

Platelet MicroRNA 365-3p Expression Correlates with High On-treatment Platelet Reactivity in Coronary Artery Disease Patients

(2019) Yueh-Chung Chen et al.   CARDIOVASCULAR DRUGS AND THERAPY

Clopidogrel Pharmacogenetics

(2019) Naveen L. Pereira et al.   Circulation-Cardiovascular Interventions

Insufficient sleep is associated with a pro‐atherogenic circulating microRNA signature

(2019) Jamie G. Hijmans et al.   EXPERIMENTAL PHYSIOLOGY

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

(2019) Joo-Yong Hahn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review

(2019) Justyna Pordzik et al.   Cardiovascular Diabetology

Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out!

(2019) Cindy L Grines et al.   EUROPEAN HEART JOURNAL

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease

(2019) Otto Mayer et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

(2019) Roxana Mehran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atherosclerosis, myocardial infarction and primary hemostasis: Impact of platelets, von Willebrand factor and soluble glycoprotein VI

(2019) Josepha-Maria Villmann et al.   THROMBOSIS RESEARCH

Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease

(2019) Marcelo A. Mori et al.   Cell Metabolism

MicroRNAs as a Potential Quality Measurement Tool of Platelet Concentrate Stored in Blood Banks—A Review

(2019) Jersey Heitor da Silva Maués et al.   Cells

MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes

(2018) Marco Witkowski et al.   Cardiovascular Diabetology

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

(2018) Karen A. Hicks et al.   CIRCULATION

Transcoronary concentration gradients of circulating microRNAs in heart failure

(2018) Salvatore De Rosa et al.   EUROPEAN JOURNAL OF HEART FAILURE

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

(2018) Pascal Vranckx et al.   LANCET

Platelet activity and hypercoagulation in type 2 diabetes

(2018) Lesha Pretorius et al.   Cardiovascular Diabetology

Resistin is a prognostic factor for death in type 2 diabetes

(2018) Agnieszka Kapłon‐Cieślicka et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients

(2017) Antoni Bayés-Genis et al.   EUROPEAN JOURNAL OF HEART FAILURE

Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS

(2017) Li Peng et al.   THROMBOSIS RESEARCH

Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation

(2017) Chang Xia et al.   Journal of Diabetes Research

Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk

(2017) Zongwei Lin et al.   Scientific Reports

Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue FactorHighlights

(2016) Marco Witkowski et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor

(2016) Annarita Carino et al.   Biomed Research International

Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity but not to Genetic Polymorphisms within BDNF Encoding Gene in Patients with Type 2 Diabetes

(2016) Ceren Eyileten et al.   MEDICAL SCIENCE MONITOR

Association of MicroRNAs and YRNAs With Platelet FunctionNovelty and Significance

(2015) Dorothee Kaudewitz et al.   CIRCULATION RESEARCH

MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics

(2015) J A Deiuliis   INTERNATIONAL JOURNAL OF OBESITY

MicroRNA deregulation in symptomatic carotid plaque

(2015) Pierre Maitrias et al.   JOURNAL OF VASCULAR SURGERY

Next-generation re-sequencing of genes involved in increased platelet reactivity in diabetic patients on acetylsalicylic acid

(2015) Marek Postula et al.   PLATELETS

miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease

(2015) Christian Schulte et al.   PLoS One

Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review

(2015) Varun Vaidya et al.   Expert Review of Pharmacoeconomics & Outcomes Research

The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy

(2015) Rui Shi et al.   Biomed Research International

Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report

(2014) Bernadeta Chyrchel et al.   PLATELETS

Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: The AVOCADO study

(2013) Marek Rosiak et al.   Cardiology Journal

Circulating MicroRNAs as Novel Biomarkers for Platelet Activation

(2013) Peter Willeit et al.   CIRCULATION RESEARCH

Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra

(2013) E. Cavarretta et al.   EUROPEAN HEART JOURNAL

Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease

(2013) Hetty C. de Boer et al.   EUROPEAN HEART JOURNAL

Early leptin blockade predisposes fat-fed rats to overweight and modifies hypothalamic microRNAs

(2013) Charlotte Benoit et al.   JOURNAL OF ENDOCRINOLOGY

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

(2013) Xi-Yong Yu et al.   EuroIntervention

New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy

(2012) Marek Postula et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Comparing the MicroRNA Spectrum between Serum and Plasma

(2012) Kai Wang et al.   PLoS One

The Repertoire and Features of Human Platelet microRNAs

(2012) Hélène Plé et al.   PLoS One

MicroRNAs in platelet biogenesis and function

(2012) Seema Dangwal et al.   THROMBOSIS AND HAEMOSTASIS

Transcoronary Concentration Gradients of Circulating MicroRNAs

(2011) Salvatore De Rosa et al.   CIRCULATION

Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes

(2011) M. POSTULA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

(2010) Anna Zampetaki et al.   CIRCULATION RESEARCH

The MicroRNA Spectrum in 12 Body Fluids

(2010) J. A. Weber et al.   CLINICAL CHEMISTRY

Clopidogrel pathway

(2010) Katrin Sangkuhl et al.   Pharmacogenetics and Genomics

Methods for the Measurement of Platelet Function

(2009) Alan D. Michelson   AMERICAN JOURNAL OF CARDIOLOGY

miR-126 Regulates Angiogenic Signaling and Vascular Integrity

(2008) Jason E. Fish et al.   DEVELOPMENTAL CELL

Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents

(2008) Arun Natarajan et al.   Diabetes & Vascular Disease Research